Survival and cardiac recovery in pediatric dilated cardiomyopathy: A long-term cohort study of risk factors, prognosis, and health outcomes followed into adulthood

儿童扩张型心肌病患者的生存和心脏恢复:一项长期队列研究,探讨风险因素、预后和健康结果,并随访至成年期

阅读:2

Abstract

BACKGROUND: Dilated cardiomyopathy (DCM) is the most common cause of pediatric heart failure (HF), but most studies focus on early survival. We examined prognostic factors and outcomes of routine care in childhood-onset DCM followed into adulthood. METHODS: From January 2001 to August 2023, we studied a cohort of patients with childhood-onset DCM using electronic medical records from a tertiary pediatric hospital and linked province-wide health care administrative data. DCM cases with or without echocardiographic recovery and matched controls were compared on demographic and disease characteristics and various health outcomes. We used Cox proportional hazards regression and cause-specific hazard models to identify prognostic factors for all-cause mortality and heart transplantation, respectively. RESULTS: Over a median follow-up of 13.8 years, DCM cases (n = 156) had higher rates of all-cause death, heart transplantation, and HF admission than controls (n = 780), as did nonrecovered (n = 103) compared with recovered cases (all p < 0.001). Cases had higher incidence rates of chronic kidney disease (p < 0.001) and diabetes (p = 0.002) than controls. As some recovered cases later died or underwent transplantation, this may constitute DCM relapse. On multivariable analysis, idiopathic and familial DCM (vs myocarditis), lower left ventricular ejection fraction, rural residence, and not receiving HF medications were associated with heart transplantation. Diagnosis in 2010-2017 (vs 2001-2009), recovery, beta blockers, and the lack of troponin I or T mutations were protective against mortality. CONCLUSIONS: Childhood DCM is associated with adverse health and increased health care utilization even into adulthood. While echocardiographic normalization and routine treatments are associated with improved prognosis, some patients may relapse after recovery.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。